|
Novel Drug Prevents Common Viral Disease in Stem-Cell Transplant Patients
Science Daily (press release) Sep. 25, 2013 — A new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells, a clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women’s … Chimerix Announces Publication of Positive Phase 2 Results of Brincidofovir …MarketWatch Cytomegalovirus—a ‘stealth’ pathogen—gains attention in the drug development …Nature Medicine blog (blog) CMX001 reduced cytomegalovirus disease after HSCTHealio |
Hanging In The Mist: Mercury Contamination In South India – Center for Research on Globalization
Center for Research on GlobalizationHanging In The Mist: Mercury Contamination In South IndiaCenter for Research on GlobalizationWith all the lush greenery, the abundance of fruits being grown and the chocolate box cottages dotting the slopes and aroun…
Liver transplant center to be set up in Guatemala – Taipei Times
Liver transplant center to be set up in GuatemalaTaipei TimesTo prepare for the establishment of the liver transplant center, 13 Guatemalan physicians completed a year-long internship program for clinical practice in liver transplantation that started …
Withhold Gliptins From Diabetics With Heart Failure? – Medscape
Medscape |
Withhold Gliptins From Diabetics With Heart Failure?
Medscape BARCELONA, Spain — New data from EXAMINE, the cardiovascular-safety trial with the type 2 diabetes drug alogliptin (Nesina, Takeda Pharmaceuticals), has shown no significantly increased risk for heart failure (HF) with use of this dipeptidyl peptidase … |
Drug companies seek to deliver patents message to Indian prime minister – Politico
Politico |
Drug companies seek to deliver patents message to Indian prime minister
Politico Drug manufacturers say India’s most egregious act came in March 2012, when its controller general of patents, designs and trademarks granted a compulsory license for local generics company Natco to sell a copy of Bayer’s Nexavar, which treats liver and … |
Research and Markets: Global Monoclonal Antibodies Pipeline Capsule – 2013 … – Fort Mills Times
|
Research and Markets: Global Monoclonal Antibodies Pipeline Capsule – 2013 …
Fort Mills Times The latest report ‘Global Monoclonal Antibodies Pipeline Capsule – 2013′ provides up-to-date information on key Research and Development activities (R&D) in the global monoclonal antibodies market. It covers active monoclonal antibodies pipeline … |
Boxed warning for HBV risk added to Rituxan, Arzerra – Clinical Advisor
Medscape |
Boxed warning for HBV risk added to Rituxan, Arzerra
Clinical Advisor The FDA has announced that the anti-CD20-directed monoclonal antibodies rituximab (Rituxan) and ofatumumab (Arzerra) will carry a boxed warning for immunosupression-related reactivation of hepatitis B virus (HBV) in a drug safety communication. Boxed Warning on HBV Reactivation for Blood Cancer DrugsMedscape FDA updates ‘box warning’ for Arzerra and Rituxan to include Hepatitis B …The Global Dispatch Boxed warning for potential HBV reactivation added to Arzerra, Rituxan labelingHealio Pharmaceutical Processing all 5 news articles » |
Project Recovery turns unused blood products from Canadian blood donations … – PR Newswire India (press release)
Project Recovery turns unused blood products from Canadian blood donations …PR Newswire India (press release)Canadian Blood Services also oversees the OneMatch Stem Cell and Marrow Network, and provides national leadership for organ and tissue donati…
Chinese man has new nose grown on his forehead – Metro
Metro |
Chinese man has new nose grown on his forehead
Metro These astonishing pictures show Xiaolian, 22, at a hospital in Fuzhou, Fujian province, as doctors check on his progress ahead of transplant surgery. The patient underwent the unusual procedure after he neglected nasal trauma treatment following a … New nose grown on man’s foreheadCANOE New nose grown by surgeons to replace original oneBBC News Amazing photos show man’s new nose grown on his foreheadAtlanta Journal Constitution International Business Times –The Frisky all 130 news articles » |
Boxed warning for potential HBV reactivation added to Arzerra, Rituxan labeling – Healio
|
Boxed warning for potential HBV reactivation added to Arzerra, Rituxan labeling
Healio Rituxan (rituximab, Genentech) is a therapy for CLL, non-Hodgkin’s lymphoma and conditions that include microscopic polyangiitis, granulomatosis with polyangiitis and rheumatoid arthritis. These drugs, along with other CD20-directed cytolytic … |